Utility of Brain Natriuretic Peptide as a Predictor of Atrial Fibrillation After Cardiac Operations

Annals of Thoracic Surgery

Volumn 88, Issue 3, 2009, Pages 802-807

  Tavakol, Morteza ^a   Hassan, Kashif Z ^a   Abdula, Raushan K ^a   Briggs, William ^a   Oribabor, Charles E ^a   Tortolani, Anthony J ^a,b   Sacchi, Terrence J ^a   Lee, Leonard Y ^a,b   Heitner, John F ^a  

^a NEW YORK METHODIST HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY DIAMETER; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORONARY ARTERY BYPASS SURGERY; DISEASE MARKER; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART VALVE SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FIBRILLATION; CARDIAC OUTPUT, LOW; COMORBIDITY; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 68849097014     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.04.021     Document Type: Article

References (34)

1. Ommen S.R., Odell J.A., and Stanton M.S. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 336 (1997) 1429-1434
2. Almassi G.H., Schowalter T., Nicolsi A.C., et al. Atrial fibrillation after cardiac surgery. A major morbid event?. Ann Surg 226 (1997) 501-513
3. Aranki S.F., Shaw D.P., Adams D.H., et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 94 (1996) 390-397
4. Matthew J.P., Parks R., Savino J.S., et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. JAMA 276 (1996) 300-306
5. Kim M.H., Deeb G.M., Morady F., et al. Effect of postoperative atrial fibrillation on length of stay after cardiac surgery. The postoperative atrial fibrillation in cardiac surgery study PACS. Am J Cardiol 87 (2001) 881-885
6. Auer J., Weber T., Berent R., et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Am Heart J 147 (2004) 636-643
7. Halonen J., Hakala T., Auvinen T., et al. Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery. Circulation 114 (2006) I 1-I 14
8. Marin F., Pascual D.A., Roldan V., et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 97 (2006) 55-60
9. Patti G., Chello M., Candura D., et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery. Results of the ARMYDA-3 (atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) study. Circulation 114 (2006) 1455-1461
10. Prasongsukran K., Abel J.G., Jamieson W.R.E., et al. The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery. J Thorac Cardiovasc Surg 130 (2005) 93-98
11. Halonen J., Halonen P., Jarvinen O., et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 297 (2007) 1562-1567
12. Borzak S., Tisdale J.E., Amin N.B., et al. Atrial fibrillation after bypass surgery. Does the arrhythmia or the characteristics of the patients prolong hospital stay?. Chest 113 (1998) 1489-1491
13. Hakala T., Hedman A., Turpeinen A., Kettunen R., Vuolteenaho O., and Hippelainen M. Prediction of atrial fibrillation after coronary artery bypass grafting by measuring atrial peptide levels and preoperative atrial dimensions. Eur J Cardiothorac Surg 22 (2002) 939-943
14. Jourdain P., Bellorini M., Funck F., et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study. Eur J Heart Fail 4 (2002) 263-267
15. Ohta Y., Shimada T., Yoshitomi H., et al. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol 17 (2001) 415-420
16. Albage A., Kenneback G., van der Linden J., and Berglund H. Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the maze procedure. Ann Thorac Surg 75 (2003) 790-795
17. Mabuchi N., Tsutamoto T., Maeda K., and Kinoshita M. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrila fibrillation in patients with mild congestive heart failure. Jpn Circ J 64 (2000) 765-771
18. Hutfless R., Kazanegra R., Madani M., et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43 (2004) 1873-1879
19. Wazni O.M., Martin D.O., Marouche N.F., et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 110 (2004) 124-127
20. Harrell F. Regression modeling strategies (2001), Springer, New York 600
21. R Development Core Team. R: a language and environment for statistical computing (2008), R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org Accessed: Apr 28, 2009
22. Lahtinen J., Biancari F., Salmela E., et al. Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery. Ann Thorac Surg 77 (2004) 1241-1244
23. Crystal E., Connolly S., Sleik K., Ginger T.J., and Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery. Circulation 106 (2002) 75-80
24. Hakala T., Pitkänen O., and Hippeläinen M. Feasibility of predicting the risk of atrial fibrillation after coronary artery bypass surgery with logistic regression model. Scand J Surg 91 (2002) 339-344
25. Taylor G.J., Malik S.A., Colliver J.A., et al. Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. Am J Cardiol 60 (1987) 905-907
26. Birnie D.H., Gollob M., and Healey J.S. Clinical trials, the rennin angiotensin system and atrial fibrillation. Curr Opin Cardiol 24 (2006) 368-375
27. Wachtell K., Lehto M., Gerdts E., et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 45 (2005) 712-719
28. White C.M., Kluger J., Lertsburapa K., Faheem O., and Coleman C.I. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg 31 (2007) 817-820
29. Young-Xu Y., Jabbour S., Goldberg R., et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 92 (2003) 1379-1383
30. Mahoney E.M., Thompson T.D., Veledar E., Williams J., and Weintraub W.S. Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J Am Coll Cardiol 40 (2002) 737-745
31. Zaman A., Archbold A., Helft G., Paul E.A., Curzen N.P., and Mills P.G. Atrial fibrillation after coronary artery bypass graft surgery. Circulation 101 (2000) 1403-1408
32. Pretorius M., Donahue B.S., Yu C., et al. Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass. Circulation 116 suppl I (2007) I-1-I-7
33. Daoud E.G., Strickberger S.A., Man C., et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337 (1997) 1785-1791
34. Villareal R.P., Hariharan R., Liu B.C., et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 43 (2004) 742-748